This topic contains a solution. Click here to go to the answer

Author Question: A male patient is receiving rituximab therapy for non-Hodgkin's lymphoma. Which of the following ... (Read 98 times)

erika

  • Hero Member
  • *****
  • Posts: 522
A male patient is receiving rituximab therapy for non-Hodgkin's lymphoma. Which of the following would be a priority nursing intervention to reduce the risk for cytotoxicity and tumor lysis syndrome?
 
  A) Ensure that the patient maintains a normal breathing pattern.
  B) Ensure that the patient maintains a normal fluid and electrolyte balance.
  C) Protect the patient from exposure to infections.
  D) Monitor the patient for deterioration in renal function.

Question 2

A 28-year-old woman has completed rituximab therapy for an autoimmune disease. She tells the nurse that she and her husband would like to start a family. The nurse will advise her to
 
  A) continue using birth control for at least 12 months.
  B) stop using birth control for the next several weeks.
  C) discontinue birth control, but avoid breast-feeding after the child is born.
  D) pursue fertility testing.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Fayaz00962

  • Sr. Member
  • ****
  • Posts: 330
Answer to Question 1

B

Answer to Question 2

A





 

Did you know?

The calories found in one piece of cherry cheesecake could light a 60-watt light bulb for 1.5 hours.

Did you know?

Critical care patients are twice as likely to receive the wrong medication. Of these errors, 20% are life-threatening, and 42% require additional life-sustaining treatments.

Did you know?

Elderly adults are living longer, and causes of death are shifting. At the same time, autopsy rates are at or near their lowest in history.

Did you know?

Today, nearly 8 out of 10 pregnant women living with HIV (about 1.1 million), receive antiretrovirals.

Did you know?

Elderly adults are at greatest risk of stroke and myocardial infarction and have the most to gain from prophylaxis. Patients ages 60 to 80 years with blood pressures above 160/90 mm Hg should benefit from antihypertensive treatment.

For a complete list of videos, visit our video library